Surgery and prolonged fasting may precipitate the development of SGLT2 inhibitor-associated ketoacidosis [175], and a systematic review of perioperative SGLT2 inhibitor-associated ketoacidosis revealed that 89% of patients presented with euglycemic ketoacidosis (blood glucose concentration of <250 mg/dL) [176]. This evidence concerns the gene SLC5A2 and diabetes mellitus.